Elizabeth G. Gibson, PharmD, PhD

Associate Director, Clinical Pharmacology
Bristol Myers Squibb

Poster(s):

• (S-082) Model-Based Approach to Support Nivolumab Subcutaneous Dose Selection in Pediatric Patients (12 to <18 Years) in Multiple Solid Tumor Indications
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT